Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
53.29
-0.25 (-0.47%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
99
100
Next >
$100 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
January 22, 2024
Via
Benzinga
If You Invested $10,000 in Moderna at the End of 2019, This Is How Much You Would Have Today
January 21, 2024
Has the stock wiped out its gains since the pandemic?
Via
The Motley Fool
1 Stock Down 43% to Buy and Hold for 10 Years
January 21, 2024
This biotech isn't just a pandemic stock.
Via
The Motley Fool
Better Bull Market Buy: Pfizer vs. Moderna
January 20, 2024
There could be a light at the end of the COVID-19 tunnel for both of these beaten-down stocks.
Via
The Motley Fool
Exposures
COVID-19
3 Stocks Poised to Bounce Back After a Brutal 2023
January 18, 2024
These companies, which badly lagged the market last year, now look to be turning things around and could be rebound stocks in the year ahead.
Via
InvestorPlace
Behind the Scenes of Moderna's Latest Options Trends
January 18, 2024
Via
Benzinga
3 Things That Could Help 2023 Loser-Stock Moderna Roar Higher in 2024
January 18, 2024
Moderna may be heading for a new era of growth.
Via
The Motley Fool
Peering Into Moderna's Recent Short Interest
January 17, 2024
Via
Benzinga
Critical Insights From Moderna Analyst Ratings: What You Need To Know
January 12, 2024
Via
Benzinga
Smart Money Is Betting Big In MRNA Options
January 10, 2024
Via
Benzinga
Alphabet, Electronic Arts And 2 Other Stocks Insiders Are Selling
January 18, 2024
The Nasdaq 100 closed lower by over 90 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
7 Mighty Healthcare Stocks Changing the Game of Medicine
January 17, 2024
Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks.
Via
InvestorPlace
3 Struggling Businesses Investors Shouldn't Gamble on This Year
January 17, 2024
These stocks all crashed heavily in 2023, and there is no reason to expect things will get a whole lot better this year.
Via
The Motley Fool
Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive'
January 17, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would back Moderna, Inc. (NASDAQ: MRNA) here.
Via
Benzinga
7 Healthcare Stocks Taking Medicine to the Next Level
January 14, 2024
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider.
Via
InvestorPlace
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,700 Today
January 09, 2024
Via
Benzinga
Moderna Stock Is Trading Higher Monday: What's Going On?
January 08, 2024
Via
Benzinga
Moderna Provides Business and Pipeline Updates at 42nd Annual J.P. Morgan Healthcare Conference
January 08, 2024
Via
ACCESSWIRE
3 Megatrend Stocks that Will Revolutionize Your Portfolio
January 11, 2024
Consider these powerhouse stocks for likely significant capital appreciation, growth, and rewards for your portfolio.
Via
InvestorPlace
Oxford University Kicks off Human Study for AstraZeneca's COVID-19 Vaccine Technology in Nipah Virus Defense
January 11, 2024
Join the fight against Nipah virus! Oxford Vaccine Group launches groundbreaking ChAdOx1 NipahB vaccine trial, targeting the deadly virus. 51 participants aged 18-55. Funded by CEPI. Help combat Nipah...
Via
Benzinga
Exposures
COVID-19
The Best Places to Invest $100,000 in 2024
January 11, 2024
Right now looks like a great time to invest in growth stocks.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
January 10, 2024
Via
Benzinga
3 health care stocks off to strong starts in 2024
January 10, 2024
With the bullish news flow lately, the market has taken a liking to health care stocks in recent weeks - including these three early 2024 gainers.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Your Path to Wealth: 3 Stocks Predicted to Double Your Investment by 2025
January 09, 2024
Unveil three standout companies set to double investments by 2025 with groundbreaking strategies in tech and healthcare.
Via
InvestorPlace
2024 Marks a New Era Of Pharmaceutical Innovation
January 09, 2024
With Covid-19 finally fading into history, the Covid-19 heroes, namely Moderna Inc (NASDAQ: MRNA) and Pfizer Inc (NYSE: PFE) were forced to redefine their business focus last year, and so, they turned...
Via
Benzinga
Exposures
COVID-19
10 Health Care Stocks Whale Activity In Today's Session
January 09, 2024
Via
Benzinga
7 S&P 500 Stocks to Buy to Keep the Bull Market Running
January 09, 2024
The S&P 500 index is approaching a new all-time high and these seven stocks will keep the bull market running.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?
January 08, 2024
These four names span different sectors, but all underperformed in 2023. Is it time to be a contrarian and pick up bargains on the discount aisle?
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
The rebound by biopharma stocks in 2023 and the pickup in M&A news flow makes the 2024 JPMorgan Healthcare conference even more interesting.
Via
Benzinga
Are defensive sectors ready to outshine growth in 2024?
January 06, 2024
Is 2024 the year defensive stocks rotate into leadership? As the year gets underway, defensives such as healthcare, energy, utilities and consumer staples lead.
Via
MarketBeat
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.